Erschienen in:
01.09.2015 | Commentary
News from the NIH: potential contributions of the behavioral and social sciences to the precision medicine initiative
verfasst von:
William T. Riley, PhD, Wendy J. Nilsen, Ph.D., Teri A. Manolio, M.D., Ph.D., Daniel R. Masys, M.D., Michael Lauer, M.D.
Erschienen in:
Translational Behavioral Medicine
|
Ausgabe 3/2015
Einloggen, um Zugang zu erhalten
Excerpt
At this year’s State of the Union address, the President announced a new $215 million Precision Medicine Initiative in the 2016 budget that will pioneer a new model of patient-empowered research that promises to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select which treatments will work best for which patients [
1,
2]. Concurrently, Directors of the National Institutes of Health and the National Cancer Institute, Drs. Francis Collins and Harold Varmus, respectively, published an article in the New England Journal of Medicine that describes two main components of this initiative, a near-term focus on cancer therapy and a longer-term effort to generate knowledge applicable to a wide range of health and disease [
3]. This longer-term initiative seeks to generate a cohort of one million or more Americans to “enable better assessment of disease risk, understanding of disease mechanisms, and the prediction of optimal therapy for many more diseases, with the goal of expanding the benefits of precision medicine into myriad aspects of health and healthcare” [
3]. …